The absence of CCR7 results in dysregulated monocyte migration and immunosuppression facilitating chronic cutaneous leishmaniasis.
The protozoan parasite Leishmania major causes cutaneous lesions to develop at the site of infection, which are resolved with a strong Th1 immune response in resistant hosts, such as C57BL/6 mice. In contrast, the lesions ulcerate in susceptible hosts which display a Th2 response, such as BALB/c mic...
Main Authors: | Jessica C Kling, Matthias Mack, Heinrich Körner |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3813618?pdf=render |
Similar Items
-
Fatal Leishmaniasis in the Absence of TNF Despite a Strong Th1 Response
by: Phillip D Fromm, et al.
Published: (2016-01-01) -
Recurrence of visceral and muco-cutaneous leishmaniasis in a patient under immunosuppressive therapy
by: Gilles Darcis, et al.
Published: (2017-07-01) -
Unusual clinical presentation of cutaneous leishmaniasis in a patient with corticosteroid‐induced immunosuppression
by: Maryam Mahdavi, et al.
Published: (2021-01-01) -
Differential impact of the dual CCR2/CCR5 inhibitor cenicriviroc on migration of monocyte and lymphocyte subsets in acute liver injury.
by: Tobias Puengel, et al.
Published: (2017-01-01) -
New insights into leishmaniasis in the immunosuppressed.
by: Hannah Akuffo, et al.
Published: (2018-05-01)